Sickle Cell Disease Coalition Releases New SCD Fact Sheets
June 08, 2021
The
Sickle Cell Disease Coalition recently released
sickle cell disease (SCD) therapy fact sheets that highlight three Food and Drug Administration-approved therapies for SCD: crizanlizumab, L-glutamine and voxelotor. The Coalition developed the fact sheets to provide patients with SCD and their caregivers high-quality, non-branded information on available therapies so that they may effectively discuss treatment options with their health care providers. The Coalition will review and update the fact sheets every six months and as new information arises. Additional resources are available on the Sickle Cell Disease Coalition’s resources
web page.